The functional help provided by four cross-linked synthetic peptides f
rom HIV-1 Gag structural proteins was investigated in the mouse model.
These peptides, selected upon non-self-criteria, are not predicted as
T epitopes by classical prediction methods such as the Rothbard conse
nsus or the amphipathy rule. Priming mice with these peptides allows t
he enhancement of the antibody response to HIV-1 Gag proteins (p55, p1
8, p24) given in the viral particle form. Furthermore, all of them als
o induce spleen and lymph node cells from primed mice to proliferate i
n vitro, in a MHC class II restricted context. This approach may help
to identify relevant immunogenic viral epitopes that may be involved i
n a vaccinal strategy.